133 related articles for article (PubMed ID: 1749475)
1. Visual toxicity following intra-arterial chemotherapy with hydroxyethyl-CNU in patients with malignant gliomas. A prospective study with statistical analysis.
Defer G; Fauchon F; Schaison M; Chiras J; Brunet P
Neuroradiology; 1991; 33(5):432-7. PubMed ID: 1749475
[TBL] [Abstract][Full Text] [Related]
2. Treatment of malignant recurrent glioma by intra-arterial, infra-ophthalmic infusion of HECNU 1-(2-chloroethyl)-1-nitroso-3-(2-hydroxyethyl) urea. A phase II study.
Poisson M; Chiras J; Fauchon F; Debussche C; Delattre JY
J Neurooncol; 1990 Jun; 8(3):255-62. PubMed ID: 2193122
[TBL] [Abstract][Full Text] [Related]
3. [Medical treatment of inoperable malignant glioma. Non-superselective intra-arterial chemotherapy with HECNU followed by conventional radiotherapy].
Chiras J; Fauchon F; Poisson M; Debussche C; Chauveinc L; Pereon Y; Guérin RA; Bories J
Rev Neurol (Paris); 1989; 145(12):829-37. PubMed ID: 2482527
[TBL] [Abstract][Full Text] [Related]
4. Phase I study of intracarotid PCNU.
Stewart DJ; Grahovac Z; Russel NA; Hugenholtz H; Gupta S; Benoit BC; Richard MT; Maroun JA; Hopkins HS; Locke L
J Neurooncol; 1987; 5(3):245-50. PubMed ID: 3681387
[TBL] [Abstract][Full Text] [Related]
5. [Intra-arterial ACNU chemotherapy of malignant glioma].
Murayama S; Kawai R; Hirabuki N; Miura T; Mitomo M; Kozuka T; Usio Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1988 Feb; 48(2):144-53. PubMed ID: 3164472
[No Abstract] [Full Text] [Related]
6. Reduction of severe visual loss and complications following intra-arterial chemotherapy (IAC) for refractory retinoblastoma.
Reddy MA; Naeem Z; Duncan C; Robertson F; Herod J; Rennie A; Liasis A; Thompson DA; Sagoo M
Br J Ophthalmol; 2017 Dec; 101(12):1704-1708. PubMed ID: 28432112
[TBL] [Abstract][Full Text] [Related]
7. Visual system toxicity following intra-arterial chemotherapy.
Kupersmith MJ; Frohman LP; Choi IS; Foo SH; Hiesinger E; Berenstein A; Wise A; Carr RE; Ransohoff J
Neurology; 1988 Feb; 38(2):284-9. PubMed ID: 3340295
[TBL] [Abstract][Full Text] [Related]
8. Ischemic optic neuropathy secondary to intracarotid infusion of BCNU.
Pickrell L; Purvin V
J Clin Neuroophthalmol; 1987 Jun; 7(2):87-92. PubMed ID: 2956289
[TBL] [Abstract][Full Text] [Related]
9. [Treatment of supratentorial glioma in adults by intra-arterial HECNU. Experience of the Pitié-Salpétrière group].
Poisson M; Chiras J; Fauchon F; Delattre JY
Rev Neurol (Paris); 1992; 148(6-7):441-7. PubMed ID: 1448664
[TBL] [Abstract][Full Text] [Related]
10. Ocular and orbital toxicity following intracarotid injection of BCNU (carmustine) and cisplatinum for malignant gliomas.
Miller DF; Bay JW; Lederman RJ; Purvis JD; Rogers LR; Tomsak RL
Ophthalmology; 1985 Mar; 92(3):402-6. PubMed ID: 2986069
[TBL] [Abstract][Full Text] [Related]
11. [Effect of intra-arterial and local administration of MCNU on cerebral malignant gliomas].
Watanabe M; Takeda N; Tanaka R
Gan To Kagaku Ryoho; 1995 May; 22(6):811-4. PubMed ID: 7755390
[TBL] [Abstract][Full Text] [Related]
12. PCNU treatment for recurrent malignant gliomas.
Levin VA; Resser KJ; McGrath L; Vestnys P; Nutik S; Wilson CB
Cancer Treat Rep; 1984; 68(7-8):969-73. PubMed ID: 6744348
[No Abstract] [Full Text] [Related]
13. Intra arterial chemotherapy with ACNU and radiotherapy in inoperable malignant gliomas.
Chauveinc L; Sola-Martinez MT; Martin-Duverneuil M; Mazeron JJ; Faillot T; Cornu P; Capelle L; Delattre JY; Poisson M; Baillet F; Chiras J
J Neurooncol; 1996 Feb; 27(2):141-7. PubMed ID: 8699236
[TBL] [Abstract][Full Text] [Related]
14. [Clinical trial of MCNU for malignant brain tumors].
Harada K; Okamoto H; Fujioka Y; Uozumi T; Kiya K; Kitaoka T; Goishi A; Sasaki U; Shima T; Inagawa T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1423-31. PubMed ID: 2990350
[TBL] [Abstract][Full Text] [Related]
15. Intra-arterial BCNU chemotherapy for treatment of malignant gliomas of the central nervous system.
Greenberg HS; Ensminger WD; Chandler WF; Layton PB; Junck L; Knake J; Vine AK
J Neurosurg; 1984 Sep; 61(3):423-9. PubMed ID: 6747681
[TBL] [Abstract][Full Text] [Related]
16. Concurrent radiotherapy: fotemustine combination for newly diagnosed malignant glioma patients, a phase II study.
Beauchesne PD; Taillandier L; Bernier V; Carnin C
Cancer Chemother Pharmacol; 2009 Jun; 64(1):171-5. PubMed ID: 19352662
[TBL] [Abstract][Full Text] [Related]
17. Fotemustine in the treatment of brain primary tumors and metastases.
Khayat D; Giroux B; Berille J; Cour V; Gerard B; Sarkany M; Bertrand P; Bizzari JP
Cancer Invest; 1994; 12(4):414-20. PubMed ID: 8032964
[TBL] [Abstract][Full Text] [Related]
18. Treatment of malignant gliomas: a new approach.
Paccapelo A; Piana C; Rychlicki F; Recchioni MA; Salvolini U; Ducati A; Bonsignori M
Tumori; 1998; 84(5):529-33. PubMed ID: 9862511
[TBL] [Abstract][Full Text] [Related]
19. Human malignant gliomas treated with chemotherapy: a pathological study.
Schiffer D; Giordana MT; Buoncristiani P; Paoletti P
Neurosurgery; 1978; 3(3):344-7. PubMed ID: 740133
[TBL] [Abstract][Full Text] [Related]
20. Limitations of high dose intra-arterial 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) chemotherapy for malignant gliomas.
Kapp J; Vance R; Parker JL; Smith RR
Neurosurgery; 1982 Jun; 10(6 Pt 1):715-9. PubMed ID: 7110545
[No Abstract] [Full Text] [Related]
[Next] [New Search]
